Janus Henderson Investors US’s Kyntra Bio KYNB Stock Holding History

Janus Henderson Investors US’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$33.6M	Buy	54,546 +595	+1%	+$362K	0.03%	519
2016 Q4	$28.9M	Sell	53,951 -6,462	-11%	-$3.23M	0.02%	552
2016 Q3	$31.3M	Sell	60,413 -5,186	-8%	-$2.44M	0.03%	520
2016 Q2	$26.9M	Sell	65,599 -4,208	-6%	-$1.93M	0.02%	526
2016 Q1	$37.2M	Buy	69,807 +622	+0.9%	+$310K	0.03%	473
2015 Q4	$52.7M	Buy	69,185 +9,366	+16%	+$6.22M	0.04%	402
2015 Q3	$32.8M	Buy	59,819 +4,204	+8%	+$2.55M	0.03%	501
2015 Q2	$32.7M	Buy	55,615 +32,637	+142%	+$19M	0.03%	514
2015 Q1	$18M	Buy	22,978 +1,428	+7%	+$1.11M	0.01%	629
2014 Q4	$14.7M	Buy	+21,550	New	+$13.9M	0.01%	648

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Janus Henderson Investors US's KYNB Position: Q1 2017 in Review

Janus Henderson Investors US increased its Kyntra Bio (KYNB) stake by 1.1% in Q1 2017, buying an estimated $362K and bringing the position to 54,546 shares worth $33.6M. The position accounts for 0.03% of the portfolio, ranked #519.

Janus Henderson Investors US first reported a position in KYNB in Q4 2014 and has held it in 10 quarters since. The position peaked at $52.7M in Q4 2015. 144 funds tracked by Wall St. Rank hold KYNB as of Q1 2017.

Janus Henderson Investors US held 54,546 shares of Kyntra Bio worth $33.6M as of Q1 2017.
Janus Henderson Investors US bought 595 Kyntra Bio shares in Q1 2017, an estimated $362K.
Kyntra Bio made up 0.03% of Janus Henderson Investors US's portfolio in Q1 2017, its #519 holding.
Janus Henderson Investors US first reported a position in Kyntra Bio in Q4 2014 and has held it in 10 quarters since.
Janus Henderson Investors US's Kyntra Bio position peaked at $52.7M in Q4 2015.
144 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.